TELIX PHARMACEUTICAL LTD (TLX)

Neutral

Insufficient data to determine institutional momentum.

Data as of Q1 2026

Loading ownership map...

Loading crowding analysis...

Loading snapshot...

Institutional Holders

Loading top holders...

Ownership trend chart requires at least 2 quarters of data.

More quarterly data is being processed.

No collected fundamentals to build a valuation model.

No collected fundamentals for a quality & risk analysis.

No collected fundamentals for a dividends & returns analysis.

No collected fundamentals for a capital-allocation analysis.

No collected fundamentals for a debt & leverage analysis.

Buy / Sell Volume by Quarter

Total shares institutions bought (green) vs sold (red) each quarter across all holders.

Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.

Ownership Map

Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.

Size by

Drag any bubble to rearrange · size = dollar value of the position

Loading ownership map...

Crowding AnalysisCrowded

Holders38of 5,944

Avg: 68

Uncrowded80th percentileCrowded

Institutional Activity

Buy/Sell Ratio1.47x

59th percentile

28 buying19 selling

+11

New

-11

Closed

+1.4M

Net shares

Ownership Concentration

Top 5: 71.5%Top 10: 91.4%

FMR22.0%

Portolan Capital Management,21.1%

LAZARD ASSET MANAGEMENT11.3%

PORTLAND INVESTMENT COUNSEL10.4%

Private Advisor Group,6.8%

Others (33)28.5%

Loading crowding analysis...

Conviction-Weighted Ownership

Median weight: 0.01%Avg weight: 0.11%Max: 0.82%High conviction (>1%): 0

FMR

Portolan Capital Management,

LAZARD ASSET MANAGEMENT

PORTLAND INVESTMENT COUNSEL

Private Advisor Group,

Integrated Wealth Concepts

Raiffeisen Bank International AG

MORGAN STANLEY

JPMORGAN CHASE &

Mariner,

Crowding AnalysisCrowded

Holders38of 5,944

Avg: 68

Uncrowded80th percentileCrowded

Institutional Activity

Buy/Sell Ratio1.47x

59th percentile

28 buying19 selling

+11

New

-11

Closed

+1.4M

Net shares

Ownership Concentration

Top 5: 71.5%Top 10: 91.4%

FMR22.0%

Portolan Capital Management,21.1%

LAZARD ASSET MANAGEMENT11.3%

PORTLAND INVESTMENT COUNSEL10.4%

Private Advisor Group,6.8%

Others (33)28.5%

Crowding AnalysisCrowded

Holders38of 5,944

Avg: 68

Uncrowded80th percentileCrowded

Institutional Activity

Buy/Sell Ratio1.47x

59th percentile

28 buying19 selling

+11

New

-11

Closed

+1.4M

Net shares

Ownership Concentration

Top 5: 71.5%Top 10: 91.4%

FMR22.0%

Portolan Capital Management,21.1%

LAZARD ASSET MANAGEMENT11.3%

PORTLAND INVESTMENT COUNSEL10.4%

Private Advisor Group,6.8%

Others (33)28.5%

Ownership Map

Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.

Size by

Drag any bubble to rearrange · size = dollar value of the position

Ownership Map

Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.

Size by

Drag any bubble to rearrange · size = dollar value of the position

Not enough quarter-end price history for a performance view. (Run collect_prices.py for this ticker.)

We haven't collected financials for TLX yet, so it can't be scored against its Healthcare peers.